Stay updated on FIDES-02: Derazantinib & Atezolizumab in Urothelial Cancer Clinical Trial
Sign up to get notified when there's something new on the FIDES-02: Derazantinib & Atezolizumab in Urothelial Cancer Clinical Trial page.

Latest updates to the FIDES-02: Derazantinib & Atezolizumab in Urothelial Cancer Clinical Trial page
- Check4 days agoChange DetectedRevision tag updated from v3.6.0 to v3.6.2 on the page, reflecting a minor version update to the site's rendering or functionality. This update does not alter study details or other visible content.SummaryDifference0.0%

- Check11 days agoNo Change Detected
- Check18 days agoChange DetectedThe page adds new help/navigation sections (How to Read a Study Record, Common Questions, How to Join a Study) and a recruitment-status note; it also reflects a header labeling change for Intervention/Treatment and a version update to Revision: v3.6.0.SummaryDifference0.3%

- Check25 days agoChange DetectedThe page now shows Revision: v3.5.5, replacing the previous Revision: v3.5.4, indicating a minor update to the page metadata.SummaryDifference0.0%

- Check47 days agoChange DetectedRevision tag on the page was updated from v3.5.3 to v3.5.4, indicating a newer build/version of the page. No changes to the study information are indicated.SummaryDifference0.0%

- Check68 days agoChange DetectedThe page’s revision/build label was incremented from v3.5.2 to v3.5.3, indicating an implementation update without changing the displayed study details.SummaryDifference0.0%

- Check75 days agoChange DetectedPage revision updated from v3.5.0 to v3.5.2.SummaryDifference0.0%

Stay in the know with updates to FIDES-02: Derazantinib & Atezolizumab in Urothelial Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the FIDES-02: Derazantinib & Atezolizumab in Urothelial Cancer Clinical Trial page.